Matches in SemOpenAlex for { <https://semopenalex.org/work/W4311366984> ?p ?o ?g. }
- W4311366984 endingPage "1553" @default.
- W4311366984 startingPage "1553" @default.
- W4311366984 abstract "To address the continued rise of multi-drug-resistant microorganisms, the development of novel drugs with new modes of action is urgently required. While humans biosynthesize the essential isoprenoid precursors isopentenyl diphosphate (IPP) and dimethylallyl diphosphate (DMAPP) via the established mevalonate pathway, pathogenic protozoa and certain pathogenic eubacteria use the less well-known methylerythritol phosphate pathway for this purpose. Important pathogens using the MEP pathway are, for example, Plasmodium falciparum, Mycobacterium tuberculosis, Pseudomonas aeruginosa and Escherichia coli. The enzymes of that pathway are targets for antiinfective drugs that are exempt from target-related toxicity. 2C-Methyl-D-erythritol 4-phosphate (MEP), the second enzyme of the non-mevalonate pathway, has been established as the molecular target of fosmidomycin, an antibiotic that has so far failed to be approved as an anti-infective drug. This review describes the development and anti-infective properties of a wide range of fosmidomycin derivatives synthesized over the last four decades. Here we discuss the DXR inhibitor pharmacophore, which comprises a metal-binding group, a phosphate or phosphonate moiety and a connecting linker. Furthermore, non-fosmidomycin-based DXRi, bisubstrate inhibitors and several prodrug concepts are described. A comprehensive structure-activity relationship (SAR) of nearly all inhibitor types is presented and some novel opportunities for further drug development of DXR inhibitors are discussed." @default.
- W4311366984 created "2022-12-25" @default.
- W4311366984 creator A5002848963 @default.
- W4311366984 creator A5006304159 @default.
- W4311366984 creator A5032248952 @default.
- W4311366984 creator A5047262318 @default.
- W4311366984 creator A5047779911 @default.
- W4311366984 creator A5048288399 @default.
- W4311366984 creator A5072519972 @default.
- W4311366984 creator A5076288295 @default.
- W4311366984 creator A5081165399 @default.
- W4311366984 date "2022-12-14" @default.
- W4311366984 modified "2023-10-14" @default.
- W4311366984 title "Over 40 Years of Fosmidomycin Drug Research: A Comprehensive Review and Future Opportunities" @default.
- W4311366984 cites W1484575345 @default.
- W4311366984 cites W149530718 @default.
- W4311366984 cites W1517980422 @default.
- W4311366984 cites W1557622163 @default.
- W4311366984 cites W166402193 @default.
- W4311366984 cites W1777715233 @default.
- W4311366984 cites W1791487808 @default.
- W4311366984 cites W1911291254 @default.
- W4311366984 cites W1912527875 @default.
- W4311366984 cites W1965807931 @default.
- W4311366984 cites W1969243089 @default.
- W4311366984 cites W1969325303 @default.
- W4311366984 cites W1970058276 @default.
- W4311366984 cites W1972393031 @default.
- W4311366984 cites W1974833847 @default.
- W4311366984 cites W1976264153 @default.
- W4311366984 cites W1976725431 @default.
- W4311366984 cites W1977444198 @default.
- W4311366984 cites W1978388528 @default.
- W4311366984 cites W1979530316 @default.
- W4311366984 cites W1980224328 @default.
- W4311366984 cites W1981756981 @default.
- W4311366984 cites W1983558064 @default.
- W4311366984 cites W1986005639 @default.
- W4311366984 cites W1993169311 @default.
- W4311366984 cites W1993187659 @default.
- W4311366984 cites W1993818604 @default.
- W4311366984 cites W1994241806 @default.
- W4311366984 cites W1998555588 @default.
- W4311366984 cites W1999458818 @default.
- W4311366984 cites W2000687555 @default.
- W4311366984 cites W2002090534 @default.
- W4311366984 cites W2002204776 @default.
- W4311366984 cites W2003219159 @default.
- W4311366984 cites W2003251866 @default.
- W4311366984 cites W2003306724 @default.
- W4311366984 cites W2004384232 @default.
- W4311366984 cites W2006546430 @default.
- W4311366984 cites W2007800348 @default.
- W4311366984 cites W2008147136 @default.
- W4311366984 cites W2008872195 @default.
- W4311366984 cites W2009461841 @default.
- W4311366984 cites W2010581291 @default.
- W4311366984 cites W2012382149 @default.
- W4311366984 cites W2013870905 @default.
- W4311366984 cites W2014694170 @default.
- W4311366984 cites W2014924075 @default.
- W4311366984 cites W2016322325 @default.
- W4311366984 cites W2017966251 @default.
- W4311366984 cites W2020158651 @default.
- W4311366984 cites W2020576710 @default.
- W4311366984 cites W2020678132 @default.
- W4311366984 cites W2021553032 @default.
- W4311366984 cites W2021997864 @default.
- W4311366984 cites W2023372492 @default.
- W4311366984 cites W2025785709 @default.
- W4311366984 cites W2028869260 @default.
- W4311366984 cites W2031612794 @default.
- W4311366984 cites W2032881444 @default.
- W4311366984 cites W2036479712 @default.
- W4311366984 cites W2038454784 @default.
- W4311366984 cites W2038897702 @default.
- W4311366984 cites W2038914330 @default.
- W4311366984 cites W2042353065 @default.
- W4311366984 cites W2042652500 @default.
- W4311366984 cites W2042826172 @default.
- W4311366984 cites W2045082044 @default.
- W4311366984 cites W2047127147 @default.
- W4311366984 cites W2047520039 @default.
- W4311366984 cites W2048365530 @default.
- W4311366984 cites W2050172943 @default.
- W4311366984 cites W2050329917 @default.
- W4311366984 cites W2054195744 @default.
- W4311366984 cites W2062597360 @default.
- W4311366984 cites W2064527262 @default.
- W4311366984 cites W2065011383 @default.
- W4311366984 cites W2065348550 @default.
- W4311366984 cites W2067944903 @default.
- W4311366984 cites W2068062063 @default.
- W4311366984 cites W2069559423 @default.
- W4311366984 cites W2070626264 @default.
- W4311366984 cites W2072548107 @default.
- W4311366984 cites W2072616338 @default.
- W4311366984 cites W2073829357 @default.